← Back to Clinical Trials
RecruitingNCT06155188
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
ConditionLeukemia
SponsorNanfang Hospital, Southern Medical University
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment60
SexALL
Min Age1 Month
Max Age18 Years
Start Date2019-09-29
Completion2026-12
All Conditions
Interventions
applying of FLU+CY post-HSCT
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
To determine if the novel regimen of PT/FLU+CY promotes cord blood engraftment in children's leukemia HSCT cohort
Eligibility Criteria
Inclusion Criteria: * children acute leukemia Exclusion Criteria: * MODS
Related Trials
NCT06155188
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childho
View Trial →
NCT07249346
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-v
View Trial →
NCT02872987
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treat
View Trial →